Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifevantage (LFVN) Cash & Equivalents (2016 - 2025)

Lifevantage (LFVN) has disclosed Cash & Equivalents for 16 consecutive years, with $10.2 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cash & Equivalents fell 52.85% year-over-year to $10.2 million, compared with a TTM value of $10.2 million through Dec 2025, down 52.85%, and an annual FY2025 reading of $20.2 million, up 19.63% over the prior year.
  • Cash & Equivalents was $10.2 million for Q4 2025 at Lifevantage, down from $13.1 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $23.2 million in Q2 2021 and bottomed at $10.2 million in Q4 2025.
  • Average Cash & Equivalents over 5 years is $18.4 million, with a median of $18.7 million recorded in 2021.
  • The sharpest move saw Cash & Equivalents surged 40.78% in 2021, then tumbled 52.85% in 2025.
  • Year by year, Cash & Equivalents stood at $20.2 million in 2021, then dropped by 13.9% to $17.4 million in 2022, then decreased by 0.22% to $17.3 million in 2023, then increased by 24.6% to $21.6 million in 2024, then crashed by 52.85% to $10.2 million in 2025.
  • Business Quant data shows Cash & Equivalents for LFVN at $10.2 million in Q4 2025, $13.1 million in Q3 2025, and $20.2 million in Q2 2025.